Andrew von Eschenbach

Type: Person
Name: Andrew von Eschenbach
Title: Commissioner
Organization: U.S. Food and Drug Administration
Date of Birth: 30/10/1941
Place of Birth: Philadelphia
Nationality: United States
Fact Sheet: Biography for Andrew von Eschenbach
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

Drug pricing: A new prescription

leo acadia for the boston globeWhat wouldThat’s the sad realization from the ongoing controversy over who pays for Sovaldi, a hepatitis C drug launched this year by Gilead Sciences and priced at $1,000 per pill, or $84,000 for a 12-week course. The drug ... [Published Boston Globe - Sep 14 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

News 8/27/14

Top NewsThe Department of Defense issues an RFP for its $11 billion EHR replacement. Dim-Sum brought up a great point in our conversation the other day: the government requires that a significant chunk of the bid be awarded to companies owned by women, ... [Published HIStalk - Aug 27 2014]
Entities: CIO, Healthcare, Google Apps
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Many voice support for the view that biotech's model is ‘falling apart’ (Video)

I got a lot of feedback from a blog post yesterday in which a former commissioner of the FDA, Andrew von Eschenbach, criticized the agency he used to head, saying it’s effectively holding back innovation.Probably the most memorable quote (and headline) ... [Published Business First of Buffalo - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Five things for Pharma Marketers to know: Tuesday, August 26

Share this article:Merck and Pfizer pursue new pembrolizumab researchMerck's experimental PD-1 cancer therapy pembrolizumab is attracting more potential allies: Pfizer and Merck announced Tuesday that they will be testing Merck's PD-1 with Pfizer's lung-cancer ... [Published Medical Marketing And Media - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

video•BBJ Report: FDA Falling Apart?

Is the Food and Drug Administration failing?The Boston Business Journal reports a former FDA head says its biotech business model "is basically falling apart."Andrew von Eschenbach said he thinks the FDA's drug trials are becoming too large and expansive, ... [Published NECN.com - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Former FDA head says biotech business model 'is basically falling apart'

A former head of the U.S. Food and Drug Administration who will help lead a discussion at Tufts University today says that the agency is holding back, rather than encouraging, the creation of groundbreaking new drugs.Andrew von Eschenbach, commissioner ... [Published Boston Business Journal - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Doctors, Biotech Leaders, and Policymakers Gather to Discuss Roadblocks to Innovation and Advancing the 21st Century Cures Initiative

The Manhattan Institute (MI) and its Project FDA, in partnership with the Tufts Center for the Study of Drug Development, will host the first in a series of public discussions about the reforms necessary to accelerate patient access to life-saving treatments, ... [Published Digital Journal - Aug 25 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

An Rx for making wonder drugs

Boston is to life-sciences innovation what Florence was to the Renaissance: a fertile hub for the blending of new ideas and technologies, revolutionizing our understanding of human biology. Boston’s ecosystem of cutting-edge hospitals, startups, venture ... [Published Boston Herald - Aug 24 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Catching Biopharmaceutical Sponsors by Surprise

The FDA has always been concerned about the safety of patients, and they strongly believe that clinical trials are not sufficient to capture all drug related adverse effects. During an update on The Future of FDA’s Drug Safety Program, Andrew C. von Eschenbach ... [Published Pharmaceutical Executive - Jul 25 2014]
First reported Apr 29 2014 - Updated Apr 29 2014 - 1 reports

CDC: Vaccines save hundreds of thousands of lives

FOXNewshealth.com senior managing editor Dr. Manny Alvarez, Preventive Medicine Research Institute president Dr. Dean Ornish, and former FDA commissioner Dr. Andrew von Eschenbach on vaccinations and health care. ... [Published FOX Business - Video - Apr 29 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

Rating the FDA by Division

In previous work, I have argued that asymmetric incentives make the FDA too risk averse with the result being excessive drug lag and drug loss. The FDA, however, is not a monolithic agency, it is divided into divisions which overseas different types ... [Published Marginal Revolution - Apr 24 2014]

More Content

All (15) | News (10) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (2) | Press Releases (0)
sort by: Date | Relevance
Drug pricing: A new prescription [Published Boston Globe - Sep 14 2014]
News 8/27/14 [Published HIStalk - Aug 27 2014]
Many voice support for the view that biotech's ... [Published Business First of Buffalo - Aug 26 2014]
Five things for Pharma Marketers to know: Tuesd... [Published Medical Marketing And Media - Aug 26 2014]
video•BBJ Report: FDA Falling Apart? [Published NECN.com - Aug 25 2014]
Former FDA head says biotech business model 'is... [Published Boston Business Journal - Aug 25 2014]
Doctors, Biotech Leaders, and Policymakers Gath... [Published Digital Journal - Aug 25 2014]
An Rx for making wonder drugs [Published Boston Herald - Aug 24 2014]
Catching Biopharmaceutical Sponsors by Surprise [Published Pharmaceutical Executive - Jul 25 2014]
CDC: Vaccines save hundreds of thousands of lives [Published FOX Business - Video - Apr 29 2014]
Rating the FDA by Division [Published Marginal Revolution - Apr 24 2014]
Reflections on 8 years of Blogging – Eye on FDA... [Published Eye on FDA - Feb 10 2014]
von Eschenbach joins Precision Health Economics [Published BioPortfolio - Jan 22 2014]
Fact Sheet for Food and Drug Administration [Published Able2Act - Jul 28 2008]
Biography for Andrew von Eschenbach [Published Able2Act - Apr 27 2007]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
CDC: Vaccines save hundreds of thousands of lives [Published FOX Business - Video - Apr 29 2014]
FOXNewshealth.com senior managing editor Dr. Manny Alvarez, Preventive Medicine Research Institute president Dr. Dean Ornish, and former FDA commissioner Dr. Andrew von Eschenbach on vaccinations and health care. ...
Rating the FDA by Division [Published Marginal Revolution - Apr 24 2014]
In previous work, I have argued that asymmetric incentives make the FDA too risk averse with the result being excessive drug lag and drug loss. The FDA, however, is not a monolithic agency, it is divided into divisions which overseas different types ...
Reflections on 8 years of Blogging – Eye on FDA... [Published Eye on FDA - Feb 10 2014]
Hello.  Eight years ago yesterday – February 9, 2006 – I began this blog with my f irst posting .  Since then, I have published 1250 more postings. Though it seems like only yesterday, 2006 was a very different time: George W. Bush was President of ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.